Pharmaceuticals · Market research

Rheumatoid Arthritis Drugs reports

Coverage across 33 countries and regions. Researched figures and forecasts come with the full report.

Get the full Rheumatoid Arthritis Drugs market evidence

The purchased report supplies researched market size, forecast, growth, segments, competition and sources.

Buy the full report Request free sample
Rheumatoid Arthritis Drugs reports by place
PlaceCurrent sizeForecastGrowthActive trialsReport
WorldIn full reportIn full reportIn full report550View report
AfricaIn full reportIn full reportIn full report36View report
APACIn full reportIn full reportIn full report125View report
AustraliaIn full reportIn full reportIn full report33View report
BrazilIn full reportIn full reportIn full report22View report
CanadaIn full reportIn full reportIn full report42View report
ChinaIn full reportIn full reportIn full report85View report
EcuadorIn full reportIn full reportIn full report0View report
EgyptIn full reportIn full reportIn full report29View report
EuropeIn full reportIn full reportIn full report150View report
FranceIn full reportIn full reportIn full report85View report
GermanyIn full reportIn full reportIn full report60View report
Hong KongIn full reportIn full reportIn full report4View report
IndiaIn full reportIn full reportIn full report6View report
ItalyIn full reportIn full reportIn full report36View report
JapanIn full reportIn full reportIn full report18View report
KenyaIn full reportIn full reportIn full report0View report
Latin AmericaIn full reportIn full reportIn full report26View report
MalaysiaIn full reportIn full reportIn full report2View report
MexicoIn full reportIn full reportIn full report15View report
Middle EastIn full reportIn full reportIn full report4View report
New ZealandIn full reportIn full reportIn full report8View report
North AmericaIn full reportIn full reportIn full report154View report
PhilippinesIn full reportIn full reportIn full report0View report
RussiaIn full reportIn full reportIn full report2View report
Saudi ArabiaIn full reportIn full reportIn full report0View report
SingaporeIn full reportIn full reportIn full report4View report
South AfricaIn full reportIn full reportIn full report7View report
SpainIn full reportIn full reportIn full report42View report
ThailandIn full reportIn full reportIn full report1View report
UAEIn full reportIn full reportIn full report1View report
UKIn full reportIn full reportIn full report46View report
USIn full reportIn full reportIn full report137View report

Public clinical research

550 active trials found worldwide on ClinicalTrials.gov.

See the public search

Latest public research

  1. Perspectives of rheumatologists on the management of late-onset rheumatoid arthritis: a nationwide cross-sectional survey.Rheumatology international, 2026
  2. Frequency of difficult-to-treat rheumatoid arthritis and associated factors at b/tsDMARD initiation in a tertiary referral center: a cross-sectional study.Rheumatology international, 2026
  3. Still the one: Transcriptional control across leukopoiesis by SPI1/PU.1.Journal of human immunity, 2026
  4. Multidimensional Patient-Reported Impact Profiles Based on the Seven RAID Domains in Patients with Rheumatoid Arthritis and Associated Factors: A Multicentre Latent Profile Analysis.Patient preference and adherence, 2026
  5. Defective macrophage plasticity exacerbates progression of inflammation in patients with rheumatoid arthritis.Frontiers in immunology, 2026

Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.